FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

At Least 4 Christian Farmers Gunned Down in Their Fields by Motorcycle Mounted Islamists in Nigeria

Breaking: WHCD Gunman Manifesto, Social Accounts Found – He Targeted Trump, Was a ‘No Kings’ Rally Attendee

White House Correspondents’ Dinner suspect checked into Hilton hotel one day before the shooting: sources

Son warns suspected killer may ‘get away with murder’ after conviction tossed in mom’s execution-style slaying

CNN Journo Called Trump ‘a Guy Who Wants Us Dead’ Minutes Before Correspondents’ Dinner Shooting

Trump faces unprecedented third assassination attempt

Flashback: When a Magnificent Cathedral Was Torched by an African Illegal Who Murdered a Priest He Lived With

Mass shooting near Indiana University injures 9, no arrests made yet

Trump’s DC beautification push wins rare Dem praise as president snaps landmarks back to life

White House Correspondents’ Dinner shooting sharpens focus on Trump’s ballroom construction proposal

Navy Sends Robots to Take Out Iranian Mines in Strait of Hormuz: Several Successful Detonations Already Reported

WHCD Shooter Was California Teacher Once Praised as ‘Teacher of the Month’

Becerra gains momentum in California governor’s race after Swalwell shake-up

House lawmakers to watch as GOP leadership tries to pass FISA extension

California DOGE leader slams Newsom, Bonta over state’s massive fraud issues: “Every day is opposite day”

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”